ProPhase Labs Announces Collaboration with Dana-Farber Cancer Institute
08 nov. 2022 08h00 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly...
ProPhase Labs to Host Third Quarter 2022 Financial Results Conference Call on Thursday, November 10, 2022 at 11:00 a.m. Eastern Time
04 nov. 2022 08h00 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 04, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, will hold a conference call on...
ProPhase Labs Announces Collaboration with G42 Healthcare
19 oct. 2022 08h00 HE
|
ProPhase Labs, Inc.
Companies target emerging markets across the globe and joint venture opportunitiesProPhase and G42 Healthcare to explore creation of advanced genomic sequencing facility in the USCompanies enter...
ProPhase Labs to Present at The ThinkEquity Conference
18 oct. 2022 08h00 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 18, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
ProPhase Labs to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 (HYBRID CONFERENCE)
06 sept. 2022 08h15 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
ProPhase Labs Announces Record Second Quarter 2022 Financial Results
11 août 2022 08h00 HE
|
ProPhase Labs, Inc.
Record Q2 2022 Net Revenues of $29.1 Million; Up 218% Year-over-Year Record Q2 2022 Net Income of $7.4 Million; Up 633% Year-over-Year Management to Host Conference Call Today at 11:00...
ProPhase Labs to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022 at 11:00 a.m. Eastern Time
04 août 2022 20h33 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Aug. 04, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, will hold a conference call on...
ProPhase Labs Announces New $6 Million Stock Repurchase Plan
26 juil. 2022 08h00 HE
|
ProPhase Labs, Inc.
Company also provides additional information on ProPhase BioPharma Garden City, NY, July 26, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a rapidly growing and...
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 juil. 2022 18h00 HE
|
ProPhase Labs, Inc.
Garden City, NY, July 21, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that it has granted an inducement stock option...
ProPhase Labs Announces Licensing of New Investigational Cancer Compounds
21 juil. 2022 08h30 HE
|
ProPhase Labs, Inc.
Confirms Quarterly Growth continues year-over-year Announces significant progress being made in Genomics Business Company to Host Live Webcast to Discuss Business Developments Today at 11:30...